Principal Investigator
Overview
Body Locations and Systems
Diagnosis and Therapy
ClinicalTrials.gov#
NCT02930018
Status
Closed for Recruitment
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Genoveva Maclean / Study Coordinator
Phone
Email Address
Purpose of Study
The ESCAPE-NA-1 study is designed to determine the safety and efficacy of the neuroprotectant, NA-1, in reducing global disability in subjects with major acute ischemic stroke (AIS) who are selected for endovascular revascularization.
Eligibility
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
Body Locations and Systems
Diagnosis and Therapy
ClinicalTrials.gov#
NCT02930018
Status
Closed for Recruitment
Start/End Dates
Locations
Vancouver General Hospital
Name/Title
Genoveva Maclean / Study Coordinator
Phone
Email Address
Purpose of Study
The ESCAPE-NA-1 study is designed to determine the safety and efficacy of the neuroprotectant, NA-1, in reducing global disability in subjects with major acute ischemic stroke (AIS) who are selected for endovascular revascularization.
Eligibility
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.